ARCB vs KMT

ARCB exhibits a severe decoupling between its market price and fundamental value, with a Piotroski F-Score of 4/9 indicating only stable to weak financial health. The stock is trading at $127.76, which is significantly above both its Graham Number ($56.42) and its growth-based Intrinsic Value ($17.08). Despite a massive 117% one-year price surge, the company is facing negative revenue growth (-2.90%) and a sharp decline in YoY EPS (-37.3%). The current valuation is unsustainable given the razor-thin operating margins (0.42%) and deteriorating earnings trend.

KMT exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a strong current ratio of 2.55, indicating high operational efficiency and liquidity. While earnings growth is explosive (91.3% YoY), the stock is currently trading at a significant premium to its Graham Number ($23.57), though it remains slightly below its growth-based intrinsic value ($42.18). The fundamental strength is heavily offset by bearish insider sentiment (4 sales, 0 buys) and a severely weak technical trend (10/100). Consequently, the stock appears fundamentally sound but technically overextended and lacking internal conviction.